Tissue Plasminogen Activator
Authors:
- Patrick D. LydenPLPatrick D. Lyden
- Umberto DeGirolamiUDUmberto DeGirolami
- Abha KochharAKAbha Kochhar
- Vincent MazzarellaVMVincent Mazzarella
- C. C. HemenwayCHC. C. Hemenway
- Paul JohnstonPJPaul Johnston
- 1 April 1988
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 45 (4) , 387-391
Abstract
• Tissue plasminogen activator (tPA) has become available for pharmacologic use, and it appears to produce relatively fewer hemorrhagic complications than the previously available, less specific thrombolytic agents. We tested the effects of tPA in several models of embolic stroke and found that neurologic damage was reduced when the drug was administered as late as 45 minutes after cerebral embolic occlusion. The mechanism of therapeutic efficacy of tPA was probably thrombolysis. Drug-induced hemorrhages did not occur when therapy was started within four hours after the onset of vascular occlusion. These results suggest that tPA may be useful for thrombolytic therapy of embolic stroke if the drug is administered rapidly after the onset of vascular occlusion.Keywords
This publication has 7 references indexed in Scilit:
- Thrombolytic therapy in stroke: possibilities and hazards.Stroke, 1986
- Randomized trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction: Verstraete M, Bory M, Erbel R, et al Lancet 842–847 Apr 13, 1985Annals of Emergency Medicine, 1985
- New approaches to thrombolytic therapy.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1984
- Thrombolysis with Human Extrinsic (Tissue-Type) Plasminogen Activator in Rabbits with Experimental Jugular Vein Thrombosis. EFFECT OF MOLECULAR FORM AND DOSE OF ACTIVATOR, AGE OF THE THROMBUS, AND ROUTE OF ADMINISTRATIONJournal of Clinical Investigation, 1983
- Thresholds in cerebral ischemia - the ischemic penumbra.Stroke, 1981
- Comparison of the Relative Fibrinogenolytic, Fibrinolytic and Thrombolytic Properties of Tissue Plasminogen Activator and Urokinase in VitroThrombosis and Haemostasis, 1981
- Reversibility of Ischemic Brain DamageArchives of Neurology, 1973